At the core of the initiative is the CL1 biological computer developed by Cortical Labs, an Australian biotechnology company.

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...

Access to biologic therapy, such as omalizumab, is a significant barrier for CSU patients in Latin America, despite high disease knowledge. Participants in the pilot program had high baseline ...

Levels of haptoglobin in serum may help predict which patients with chronic spontaneous urticaria will achieve complete ...

Explore the vital role of academic reform in strengthening paramedics and allied health professionals for a resilient ...

After infection with the SARS-CoV-2 virus, up to ten percent of those affected in Germany develop Long COVID. The symptoms ...

Advancements in spatial proteomics enable detailed tissue mapping, linking protein localization to disease mechanisms and ...

The partnership is supported by the Michael J. Fox Foundation, which seeks to better understand aSyn protein's role in Parkinson's disease.

When approached with intention, diagnostic pathology shifts fear into understanding, apprehension into purpose, and leaves a lasting mark on how a veterinarian approaches medicine and their role ...

Not only do women get more migraines than men, but a new study shows they also experience them for a longer duration.

The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...

Chronic inflammation may be quietly reshaping the colon and making it more vulnerable to early-onset colorectal cancer. Scientists found that colon tissue in younger patients was stiffer, even in ...